Chemical Component Summary

NameN-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide
Identifiers~{N}-[(2~{S},3~{S})-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxy-propanamide
FormulaC27 H25 Cl F3 N3 O2
Molecular Weight515.955
TypeNON-POLYMER
Isomeric SMILESC[C@@H]([C@@H](Cc1ccc(cc1)Cl)c2cccc(c2)C#N)NC(=O)C(C)(C)Oc3ccc(cn3)C(F)(F)F
InChIInChI=1S/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m0/s1
InChIKeyQLYKJCMUNUWAGO-GAJHUEQPSA-N

Chemical Details

Formal Charge0
Atom Count61
Chiral Atom Count2
Bond Count63
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB06624 
NameTaranabant
Groups investigational
SynonymsTaranabant
IndicationInvestigated for use/treatment in obesity.
Categories
  • Cannabinoid Receptor Agonists
  • Cannabinoids and similars
  • Hormones
  • Hormones, Hormone Substitutes, and Hormone Antagonists
  • Neurotransmitter Agents
CAS number701977-09-5

Related Resource References

Resource NameReference
Pharos CHEMBL220360
PubChem 11226090
ChEMBL CHEMBL220360